In a 13G filing
on Flamel Technologies (Nasdaq: FLML
), Daniel Loeb's Third Point LLC disclosed a 9.2% stake (2.2 million shares) in the company. This is up from the 225,000 share stake the firm disclosed at the quarter ended March 31, 2007.
Loeb is a known activist investor and Flamel is already under activist pressure from Redwood Asset Management, which is calling for a sale.
Flamel Technologies, S.A. is a biopharmaceutical company principally engaged in the development of two unique polymer-based delivery technologies for medical applications.
Does this stock really matter to you?
Consider PRO Alerts on FLML
Now that you’ve read this, are you Bullish or Bearish on ?
Sentiment on ()
Thanks for sharing your thoughts.
Why are you ?
Submit & View ResultsSkip to results »